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ORIGINAL ARTICLE
iNTRODUCTiON
It is estimated that more than half of people in 
the world has been infected by Helicobacer pylori 
(H. pylori).
1
 The prevalence of H. pylori in 
Indonesia is more than 80%.
2
 H. pylori infection may 
cause gastritis which includes dyspepsia 40%, gastric 
ulcer 15% and gastric cancer 2% patients, respectively.
2
 
H. pylori is one of the risk factors that trigger gastric 
carcinogenesis cascade, known as Correa cascade. This 
cascade is initiated by chronic gastritis, followed by 
gastric atrophy, intestinal metaplasia and dysplasia and 
finally develops a gastric cancer.
3
 
Genetically, there is polymorphism of H. pylori in 
human population.
4-9
 Cag island and vacA strains of H. 
pylori are examples for H. pylori polymorphism, which 
may affect the clinical outcome and balance.
10-11
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The goal of this study was to discover 
the topographic localization of CagA-positive strains 
of H. pylori and its correlation with histopathological 
scoring of gastritis compared to CagA-negative strains 
of H. pylori.    
MATERiAlS AND METHODS
The protocol was approved by the Institutional 
Review Board of the Margono Soekarjo hospital, 
Purwokerto; while the study was conducted on 
dyspeptic patients at Department of Internal Medicine, 
Faculty of Medicine, University of Jenderal Soedirman/
Margono Soekarjo hospital, Purwokerto between 
2 January and 31 December 2005.
According to Rome II Criteria, dyspepsia is defined 
as chronic or recurrent pain or discomfort referable to 
ABSTRACT
Background: CagA gene is a marker for the presence of Cag pathogenicity island. CagA-pos-
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detecting Helicobacter pylori genes and CagA strain. Topographic localization of Helicobacter pylori was clas-
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upper gastrointestinal tract. Epigastric discomfort is 
a negative subjective feeling, a mild pain which may 
be accompanied by other various symptoms includ-
ing rapid satiety, bloating and nausea.
12
 Prominent 
epigastric pain or discomfort suggests dyspepsia, 
whereas esophageal reflux has other prominent 
symptoms such as heartburn or acid regurgitation.
13
Criteria for eligibility in this study were patients 
with uninvestigated dyspepsia, age > 45 years and had 
signed informed consent form. The exclusion criteria 
were patients with alarm symptoms (family history of 
upper-gastrointestinal malignancy, unexplained weight 
loss, GI bleeding, progressive dysphagia, odynophagia, 
unexplained iron-deficiency anemia, persistent 
vomiting, palpable mass or lymphadenopathy and 
jaundice),
14
 symptoms of gastroesophageal reflux, 
patients who have been under regular medication of 
non-steroid anti-inflammatory drugs (NSAIDs), 
proton pump inhibitors, histamine H
2
-receptor 
antagonists, and antibiotics for at least 4 weeks prior 
to the study, history of upper GI tract surgery and 
pregnancy. Body mass index (BMI) was calculated as 
body weight (in kilograms) divided by the square of 
the height (in meters).
15
In all patients, endoscopy and biopsy evaluation 
were performed on gastric antrum and gastric corpus, 
which included two specimens for each location. 
A group of specimens had paraffination, cut and 
hematoxilin-eosin staining for histopathological 
examination.
16
 Histopathological scoring was based on 
Chen et al method by evaluating the score of chronic, 
atrophic, and intestinal metaplasia  inflammation 
infiltrate. Score 0 = normal, 1 = mild, 2 = moderate, 
3 = severe.
17
The other group of specimens was evaluated 
for H. pylori detection by PCR method, using PCR 
reagent kit: PCR Core System (Promega #M7660, 
Promega Corp. Madison WI, USA). We used primer 
of  UreC/glmM with a sequence of  
primers at 45
o
C for 1 minute, and extension of nascent 
strands by DNA polymerase by incubation at 72
o
C 
for one minute. For detecting CagA gene, we used 
primer of
ureC1 5’GGATAAGCTTTTAGGGGTGTTAGGGG-3’
ureC2 5’-GCTTGCTTTCTAACACTAACGCGC-3’ 
(Invitrogen, Tokyo Japan)
and amplification target of 294 bp. Amplification 
procedures were as follows: samples were treated 
by 30 cycles of incubation at 94
o
C for 1 minute for 
denaturation of ds-DNA, followed by annealing of 
cagA1 5’-ATAATGCTAAATTAGACAACTTGAGCGA-3’
cagA2 5’-AGAAACAAAAGCAATACGATCATTC-3’
and amplification target of 298 bp. Amplification 
procedures were as follows: denaturation at 95
o
 for 
30 seconds, annealing at 54
o
C for 1 minute, extension 
at 72
o
C for 1.5 minute. Each reaction had 35 cycles 
using MyCycler machine (Biorad 170-9703, Biorad 
Corp USA). PCR products were analyzed by using 
Biorad Minisub DNA Cell (Biorad, USA) with 2% 
agarose gel and Tri Borate buffer at constant voltage 
of 100 V for approximately 1 hour. DNA strands were 
observed by ethidium bromide staining and ultra violet 
light. The size of DNA bp was determined by using 
Low DNA Mass Ladder (Invitrogen, USA). Gel image 
was recorded on Polaroid film by using MP4+ Camera 
System (Polaroid, USA). The result was considered as 
positive-H. pylori if there was DNA strand with the size 
of approximately 294 bp on cagA 298 bp.
18
Descriptive statistical analysis for categorical 
variables were expressed as frequency distribution 
and proportion (n and %), while continuous numeric 
variables were expressed as mean value and standard 
deviation (SD). Data normality was analyzed by 
Kolmogorov-Smirnov test, whereas data correlation 
was analyzed by Spearman test. The difference of 
histopathologic grading was analyzed by Mann-Whit-
ney U. A p value of < 0.05, 95% confidence interval 
and 80% power were taken as the limit of significance. 
Statistical analysis was conducted by using SPSS 
version 11.5 for Windows computer program.   
RESUlTS
Of 448 dyspeptic patients, 104 subjects were 
included in the study and 38 subjects were 
H. pylori-positive. Female subjects were greater in 
amount of 20 patients (52.6%) compared to male 
subjects. The ratio of female to male subjects was 10:9. 
There were 33 subjects (86.8%) with CagA-positive 
among H. pylori-positive patients. There was no 
significant difference (p > 0.05) of age, gender and 
body mass index (BMI) between both groups of 
patients with CagA-positive and CagA-negative strains 
of H. pylori (table 1).
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Patient distribution of cagA H. pylori in various 
chronic gastritis grading in antrum are shown in figure 
1 and in chronic gastritis grading in gastric corpus are 
shown in figure 2. 
Based on Spearman correlation test, there was no 
correlation between chronic gastritis grading, either 
in antrum or gastric corpus, and cagA-positive and 
cagA-negative strain of H. pylori (table 2)
DiSCUSSiON
Helicobacter pylori  strains and the cag 
pathogenicity island (PAI) have been known as 
virulent phenotype.
19
 CagPAI gene is an area of 40-kb 
DNA containing about 30 genes which may code type 
IV secretion system.
20
 CagA is one of cagPAI genes 
which most commonly found in H. pylori.
21,22
 CagA 
protein is translocated into gastric epithelial cells and 
experiencing tyrosine phosphorilation.
20,23
Phosphorylated-cagA has important roles in 
gastric carcinogenesis,
24
 interleukin  (IL-8) synthesis 
by gastric epithelial cells,
19,21,25
 renewing of surface 
cells and pedestal forming.
26,27
 IL-8 is important for 
chemotaxis and neutrophils activation.
22
 Further-
more, it also associated with the grade of neutrophils 
infiltration in gastric mucosa infected by H. pylori.
28
 
Colonization of cagA-positive strains of   H. pylori is 
correlated to increased risk of peptic ulcer and gastric 
cancer.
29
 Infection of certain H. pylori are varied based 
on socio-economic condition, patient’s age, and the 
country development status. CagA strains of H. pylori 
predominate in developing countries and it is almost 
about 100% in some Asian countries.
By PCR examination, H. pylori-positive is 
detected in 38 subjects and there are 33 (86.8%) 
subjects with cagA-positive strains of H. pylori; 
while in some Asian country, there are almost 100% 
cagA-positive strains of H. pylori.
30-34
 Similar results 
are found in Latin America, i.e. about 50-80%
35
 and 
in Kuwait 87%.
36
 Lower rate are found in Egypt 79%, 
37
 Turkey 61.7%,
38
 and Srilanka 47.5%.
39 
  
CagA-positive strains of H. pylori is associ-
ated with increased intensity of gastric inflammation, 
increased cytokine level especially IL-8 and dis-
ease progression of peptic ulcer and gastric cancer. 
Therefore, cagA-positive strains of H. pylori may 
generate higher immune response compare to the 
cagA-negative strains.
40
 
Atherton et al, conclude 
that colonization density of cagA-positive strains of 
H. pylori in antrum is significantly higher than the ca-
gA-negative strains.
41 
 However, in this study, we found 
no significant correlation of topography of chronic 
gastritis H. pylori in antrum and gastric corpus in 
cagA-positive strains of H. pylori compare to 
Figure 1. Patient distribution of cagA Helicobacter pylori in chronic 
gastritis grading in antrum
Figure 2. Patient distribution of cagA Helicobacter pylori  in chronic 
gastritis grading in gastric corpus
Table 2. Correlation of chronic gastritis grading in antrum and 
gastric corpus with cagA status
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cagA-negative strains. Similar result has been reported 
by Twisk et al
42
 and it has been proven that cagA 
status of H. pylori does not determine patient’s 
clinical status. Therefore, cagA status of H. pylori can 
not be used in clinical diagnosis.
43
    
CONClUSiON
In this study, the cagA status of Helicobacter 
pylori does not correlated to chronic gastritis grading. 
Furthermore, the topographic distribution of H. py-
lori is not determined by cagA status of Helicobacter 
pylori
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